DD139903A5 - Testverfahren zur diagnose von malignomen - Google Patents

Testverfahren zur diagnose von malignomen Download PDF

Info

Publication number: DD139903A5
Authority: DD; German Democratic Republic
Prior art keywords: test; test method; migration; sample; antigen
Prior art date: 1977-12-12

Application number

DD78209631A

Other languages

German (de)

English (en)

Inventor

Friedrich Douwes

Original Assignee

R & Z Vermoegensverw Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-12-12

Filing date

1978-12-08

Publication date

1980-01-23

1978-12-08 Application filed by R & Z Vermoegensverw Gmbh filed Critical R & Z Vermoegensverw Gmbh

1980-01-23 Publication of DD139903A5 publication Critical patent/DD139903A5/de

Links

238000010998 test method Methods 0.000 title claims description 17
238000003745 diagnosis Methods 0.000 title claims description 8
238000012360 testing method Methods 0.000 claims description 44
239000000427 antigen Substances 0.000 claims description 39
102000036639 antigens Human genes 0.000 claims description 39
108091007433 antigens Proteins 0.000 claims description 39
238000013508 migration Methods 0.000 claims description 35
230000005012 migration Effects 0.000 claims description 35
206010028980 Neoplasm Diseases 0.000 claims description 27
108010074506 Transfer Factor Proteins 0.000 claims description 24
239000000725 suspension Substances 0.000 claims description 24
210000000265 leukocyte Anatomy 0.000 claims description 21
210000004698 lymphocyte Anatomy 0.000 claims description 21
229920001817 Agar Polymers 0.000 claims description 16
239000008272 agar Substances 0.000 claims description 16
230000005764 inhibitory process Effects 0.000 claims description 15
238000000034 method Methods 0.000 claims description 15
239000006228 supernatant Substances 0.000 claims description 12
210000004369 blood Anatomy 0.000 claims description 11
239000008280 blood Substances 0.000 claims description 11
201000011510 cancer Diseases 0.000 claims description 11
239000002609 medium Substances 0.000 claims description 11
210000000056 organ Anatomy 0.000 claims description 9
230000008859 change Effects 0.000 claims description 8
239000011521 glass Substances 0.000 claims description 7
238000000338 in vitro Methods 0.000 claims description 7
238000011534 incubation Methods 0.000 claims description 6
210000004881 tumor cell Anatomy 0.000 claims description 5
238000006243 chemical reaction Methods 0.000 claims description 4
241000282412 Homo Species 0.000 claims description 3
239000012503 blood component Substances 0.000 claims description 3
230000001413 cellular effect Effects 0.000 claims description 3
239000007788 liquid Substances 0.000 claims description 3
239000003125 aqueous solvent Substances 0.000 claims description 2
239000000470 constituent Substances 0.000 claims description 2
230000002401 inhibitory effect Effects 0.000 claims description 2
239000000463 material Substances 0.000 claims description 2
230000007704 transition Effects 0.000 claims description 2
239000006916 nutrient agar Substances 0.000 claims 1
230000004936 stimulating effect Effects 0.000 claims 1
239000000243 solution Substances 0.000 description 38
210000004027 cell Anatomy 0.000 description 25
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
210000001519 tissue Anatomy 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
230000003211 malignant effect Effects 0.000 description 9
239000008188 pellet Substances 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
229920000936 Agarose Polymers 0.000 description 7
201000009030 Carcinoma Diseases 0.000 description 7
239000012153 distilled water Substances 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
239000000126 substance Substances 0.000 description 7
206010006187 Breast cancer Diseases 0.000 description 6
208000026310 Breast neoplasm Diseases 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
238000013459 approach Methods 0.000 description 6
230000036210 malignancy Effects 0.000 description 6
101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
230000028993 immune response Effects 0.000 description 5
102000004169 proteins and genes Human genes 0.000 description 5
108090000623 proteins and genes Proteins 0.000 description 5
239000000523 sample Substances 0.000 description 5
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
210000000601 blood cell Anatomy 0.000 description 4
201000008275 breast carcinoma Diseases 0.000 description 4
239000000203 mixture Substances 0.000 description 4
230000007935 neutral effect Effects 0.000 description 4
230000004044 response Effects 0.000 description 4
102000004142 Trypsin Human genes 0.000 description 3
108090000631 Trypsin Proteins 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
239000007853 buffer solution Substances 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
210000003714 granulocyte Anatomy 0.000 description 3
210000002540 macrophage Anatomy 0.000 description 3
238000005259 measurement Methods 0.000 description 3
235000015097 nutrients Nutrition 0.000 description 3
239000012588 trypsin Substances 0.000 description 3
238000010792 warming Methods 0.000 description 3
206010001233 Adenoma benign Diseases 0.000 description 2
206010006895 Cachexia Diseases 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
208000007659 Fibroadenoma Diseases 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
101000794475 Schistosoma mansoni Calcium-binding protein Proteins 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
210000005013 brain tissue Anatomy 0.000 description 2
201000003149 breast fibroadenoma Diseases 0.000 description 2
230000007969 cellular immunity Effects 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
210000002808 connective tissue Anatomy 0.000 description 2
238000001514 detection method Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
238000000605 extraction Methods 0.000 description 2
125000001475 halogen functional group Chemical group 0.000 description 2
238000011835 investigation Methods 0.000 description 2
239000000047 product Substances 0.000 description 2
238000004080 punching Methods 0.000 description 2
238000011084 recovery Methods 0.000 description 2
208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
208000002699 Digestive System Neoplasms Diseases 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
208000017604 Hodgkin disease Diseases 0.000 description 1
208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
238000012951 Remeasurement Methods 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
238000009534 blood test Methods 0.000 description 1
238000009835 boiling Methods 0.000 description 1
208000030270 breast disease Diseases 0.000 description 1
239000000872 buffer Substances 0.000 description 1
244000309466 calf Species 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
238000011109 contamination Methods 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
230000003412 degenerative effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000005684 electric field Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000001712 encephalitogenic effect Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000011888 foil Substances 0.000 description 1
235000019256 formaldehyde Nutrition 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
238000012812 general test Methods 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
239000012488 sample solution Substances 0.000 description 1
239000013049 sediment Substances 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
230000001235 sensitizing effect Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
238000007711 solidification Methods 0.000 description 1
230000008023 solidification Effects 0.000 description 1
238000000527 sonication Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000011146 sterile filtration Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000013595 supernatant sample Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000012085 test solution Substances 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Physiology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Materials By Optical Means (AREA)
Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

DD78209631A 1977-12-12 1978-12-08 Testverfahren zur diagnose von malignomen DD139903A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE2755363A DE2755363C3 (de)	1977-12-12	1977-12-12	Testverfahren zur Diagnose von Malignomen

Publications (1)

Publication Number	Publication Date
DD139903A5 true DD139903A5 (de)	1980-01-23

Family

ID=6025947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD78209631A DD139903A5 (de)	1977-12-12	1978-12-08	Testverfahren zur diagnose von malignomen

Country Status (25)

Country	Link
JP (1)	JPS54100176A (fr)
AR (1)	AR220356A1 (fr)
AT (1)	AT360178B (fr)
AU (1)	AU4234978A (fr)
BE (1)	BE872651A (fr)
CA (1)	CA1129319A (fr)
CH (1)	CH646793A5 (fr)
DD (1)	DD139903A5 (fr)
DE (1)	DE2755363C3 (fr)
DK (1)	DK532678A (fr)
ES (2)	ES475905A1 (fr)
FI (1)	FI783782A7 (fr)
FR (1)	FR2411412A1 (fr)
GB (1)	GB2009927B (fr)
GR (1)	GR66576B (fr)
IL (1)	IL56152A0 (fr)
IT (1)	IT1160323B (fr)
LU (1)	LU80609A1 (fr)
NL (1)	NL7811903A (fr)
NO (1)	NO784096L (fr)
PL (1)	PL112675B1 (fr)
PT (1)	PT68891A (fr)
RO (1)	RO75333A (fr)
SE (1)	SE432157B (fr)
ZA (1)	ZA786908B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4436824A (en) *	1981-06-09	1984-03-13	Ortho Diagnostic Systems, Inc.	Leukocyte migration through antigen containing agaroses for immunocompetence testing
JPH0672158B2 (ja) *	1984-05-24	1994-09-14	チバ−ガイギ− アクチエンゲゼルシヤフト	精製されたヒトマクロファージ遊走阻止因子

1977
- 1977-12-12 DE DE2755363A patent/DE2755363C3/de not_active Expired
1978
- 1978-11-29 GR GR57767A patent/GR66576B/el unknown
- 1978-11-29 SE SE7812313A patent/SE432157B/sv unknown
- 1978-11-29 DK DK532678A patent/DK532678A/da unknown
- 1978-12-01 CH CH1232978A patent/CH646793A5/de not_active IP Right Cessation
- 1978-12-04 LU LU80609A patent/LU80609A1/de unknown
- 1978-12-06 AT AT872478A patent/AT360178B/de active
- 1978-12-06 NO NO784096A patent/NO784096L/no unknown
- 1978-12-06 NL NL7811903A patent/NL7811903A/xx not_active Application Discontinuation
- 1978-12-07 IL IL56152A patent/IL56152A0/xx unknown
- 1978-12-08 GB GB7847795A patent/GB2009927B/en not_active Expired
- 1978-12-08 DD DD78209631A patent/DD139903A5/de unknown
- 1978-12-08 AU AU42349/78A patent/AU4234978A/en active Pending
- 1978-12-08 FI FI783782A patent/FI783782A7/fi unknown
- 1978-12-09 RO RO7895854A patent/RO75333A/fr unknown
- 1978-12-11 ZA ZA00786908A patent/ZA786908B/xx unknown
- 1978-12-11 PT PT68891A patent/PT68891A/pt unknown
- 1978-12-11 FR FR7834749A patent/FR2411412A1/fr active Granted
- 1978-12-11 BE BE2057477A patent/BE872651A/xx not_active IP Right Cessation
- 1978-12-11 ES ES475905A patent/ES475905A1/es not_active Expired
- 1978-12-12 PL PL1978211672A patent/PL112675B1/pl unknown
- 1978-12-12 JP JP15459078A patent/JPS54100176A/ja active Pending
- 1978-12-12 AR AR274770A patent/AR220356A1/es active
- 1978-12-12 IT IT30722/78A patent/IT1160323B/it active
- 1978-12-12 CA CA317,809A patent/CA1129319A/fr not_active Expired
1979
- 1979-05-25 ES ES1979243564U patent/ES243564Y/es not_active Expired

Also Published As

Publication number	Publication date
RO75333A (fr)	1980-11-30
JPS54100176A (en)	1979-08-07
CH646793A5 (de)	1984-12-14
PL112675B1 (en)	1980-10-31
PT68891A (en)	1979-07-24
IT1160323B (it)	1987-03-11
ATA872478A (de)	1980-05-15
AT360178B (de)	1980-12-29
SE432157B (sv)	1984-03-19
NO784096L (no)	1979-06-13
FR2411412A1 (fr)	1979-07-06
NL7811903A (nl)	1979-06-14
ZA786908B (en)	1979-12-27
DE2755363A1 (de)	1979-06-13
CA1129319A (fr)	1982-08-10
DE2755363C3 (de)	1983-12-01
GB2009927B (en)	1982-10-06
SE7812313L (sv)	1979-06-13
FR2411412B3 (fr)	1981-03-27
GR66576B (fr)	1981-03-27
AR220356A1 (es)	1980-10-31
DK532678A (da)	1979-06-13
IT7830722A0 (it)	1978-12-12
BE872651A (nl)	1979-03-30
PL211672A1 (pl)	1979-09-10
AU4234978A (en)	1979-06-21
ES243564U (es)	1980-06-01
IL56152A0 (en)	1979-03-12
ES475905A1 (es)	1979-10-16
ES243564Y (es)	1980-12-16
GB2009927A (en)	1979-06-20
DE2755363B2 (de)	1979-12-20
LU80609A1 (de)	1979-05-16
FI783782A7 (fi)	1979-06-13

Publication	Publication Date	Title
DE3872588T2 (de)	1992-12-03	Vereinfachtes verfahren zur herstellung von menschlichen lymphokinaktivierten killerzellen.
DE3027105C2 (fr)	1988-08-25
Delamare	1904	The lymphatics
DE3109252C2 (de)	1987-02-26	Verfahren und Zusammensetzung zur Bestimmung einzelner Leukozyten durch metachromatische Farbstoffdifferentialabsorption
DE60201582T2 (de)	2005-02-17	Pflaster zur bestimmung des zustands der sensibilisierung eines subjekts für ein allergen
DE2648458C2 (de)	1982-12-23	Verfahren zum Nachweis eines im Serum von Krebspatienten vorkommenden, spezifischen Proteins und Reagenz zur Durchführung dieses Verfahrens
Autian	1975	Biological model systems for the testing of the toxicity of biomaterials
CH648330A5 (de)	1985-03-15	Tumor-spezifische glykoproteine und verfahren zu deren herstellung.
Cuadra et al.	1969	The relationship of Bartonella bacilliformis to the red blood cell as revealed by electron microscopy
DE2635065A1 (de)	1977-02-17	Verfahren zur halbkontinuierlichen behandlung von gesamtblut
MacKIE et al.	1976	Lymphocyte abnormalities in mycosis fungoides
DE69329340T2 (de)	2001-02-01	Aufbewahren von stammzellen
DD139903A5 (de)	1980-01-23	Testverfahren zur diagnose von malignomen
Kessler et al.	1979	Thermotaxis, chemotaxis and age
DE60023474T2 (de)	2006-06-29	Methode zur selektiven trennung von blutzellen unter verwendung von lektin
EP0472772A1 (fr)	1992-03-04	Procédé pour la préparation d'érythrocytes humains vitaux chargés d'une substance active
DE68926121T2 (de)	1996-10-17	Präparat von blutzellen spezifischer dichte für den scm-test
DE2441536C3 (de)	1980-09-11	Diagnostisches Verfahren
CH639102A5 (en)	1983-10-31	Process for the preparation of recognins, their complexes, of antirecognins and their complexes and use of the complex prepared
DE10018681B4 (de)	2005-07-14	Therapeutisches Mittel für die autologe Immuntherapie von Tumoren sowie Verfahren zur Herstellung eines solchen Mittels
DE2406084A1 (de)	1974-08-15	Immunodepressives anti-humanlymphozytenserum und verfahren zu dessen herstellung
RU94036710A (ru)	1997-03-27	Способ определения терапевтической чувствительности к кетотифену больных с аллергическими заболеваниями
DE1903050A1 (de)	1969-09-25	Verfahren zur Feststellung und Lokalisation von neoplastischem Zellmaterial
DE19505795C1 (de)	1996-08-14	Proteine enthaltende Komponente aus Thujapflanzen sowie diese enthaltende Arzneimittel
Delamare	1904	The Lymphatics: General Anatomy of the Lymphatics